ResearcherUniversity of Wisconsin–MadisonActive in the last 2 years

Md. Mahfuzur Rahman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1965-9836; OpenAlex author ID A5027585474. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2025: 1 paper

Papers 1

Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic cancer models. Co-author DOI 10.1126/sciadv.adx2984 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Michael Frederick Bassetti · 1 shared paper, 2025 · strength 0.20
- Paper Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic can… DOI 10.1126/sciadv.adx2984 ↗
Zachary Scott Morris · 1 shared paper, 2025 · strength 0.20
- Paper Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic can… DOI 10.1126/sciadv.adx2984 ↗
Randall J. Kimple · 1 shared paper, 2025 · strength 0.20
- Paper Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic can… DOI 10.1126/sciadv.adx2984 ↗
Amato J. Giaccia · 1 shared paper, 2025 · strength 0.20
- Paper Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic can… DOI 10.1126/sciadv.adx2984 ↗
Nataliya Volodymyrivna Uboha · 1 shared paper, 2025 · strength 0.20
- Paper Combined innate immune cell therapy, tumor-specific antibody, and radiation prompt antitumor response in pancreatic can… DOI 10.1126/sciadv.adx2984 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.